Montreal cognitive assessment (MoCA) is a test providing a brief screening for people with cognitive impairment due to aging or neurodegenerative syndromes. In Italy, as in the rest of the world, several validation studies of MoCA have been carried out. This study compared, for the first time in Italy, a sample of people with probable Alzheimer’s Disease (AD) with healthy counterparts. The study also compared two community-dwelling groups of aged participants with and without probable cognitive impairment, as discriminated by two cut-off points of adjusted MMSE score. All the comparisons were carried out according to ROC statistics. Optimal cutoff for a diagnosis of probable AD was a MoCA score ≤14. Optimal cutoff for the discrimination of ...
Background: The early detection of neurocognitive disorders, especially when mild, is a key issue of...
Background/Aims: Performance on the Montreal Cognitive Assessment (MoCA) has been demonstrated to be...
Background: The early detection of neurocognitive disorders, especially when mild, is a key issue of...
Montreal cognitive assessment (MoCA) is a test providing a brief screening for people with cognitive...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
Background: The early detection of neurocognitive disorders, especially when mild, is a key issue of...
Background: The early detection of neurocognitive disorders, especially when mild, is a key issue of...
Background/Aims: Performance on the Montreal Cognitive Assessment (MoCA) has been demonstrated to be...
Background: The early detection of neurocognitive disorders, especially when mild, is a key issue of...
Montreal cognitive assessment (MoCA) is a test providing a brief screening for people with cognitive...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to as...
Background: The early detection of neurocognitive disorders, especially when mild, is a key issue of...
Background: The early detection of neurocognitive disorders, especially when mild, is a key issue of...
Background/Aims: Performance on the Montreal Cognitive Assessment (MoCA) has been demonstrated to be...
Background: The early detection of neurocognitive disorders, especially when mild, is a key issue of...